Physician profile
Ruby Gardner
NPI 1770010118
$1,547.18
in general payments reported to CMS, 2019-2025
10 companies · $75.01 in 2025
The $75.01 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.25 · 2022: $34.98 · 2023: $48.38 · 2024: $1,377 · 2025: $75.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $964 · Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $964.08 |
| Food and Beverage | $535.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Suvon Surgical LLC | $905.14 | 2024 | |
| Arthrex, INC. | $204.95 | 2024 | |
| Nevro Corp. | $180.30 | 2024 | Senza |
| Stryker Corporation | $97.78 | 2023-2025 | Prostep, Citrefix, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $63.11 | 2024 | |
| Smith+Nephew, INC. | $34.98 | 2022 | |
| Orthofix Medical, INC. | $19.28 | 2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.88 | 2023 | Jublia |
| Paratek Pharmaceuticals, INC. | $14.51 | 2023 | Nuzyra |
| Davol INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.